$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

스트레스로 유발된 무균 염증이 우울증 발생에 미치는 영향
Effects of Stress-Induced Sterile Inflammation on the Development of Depression 원문보기

생명과학회지 = Journal of life science, v.33 no.12, 2023년, pp.1062 - 1073  

서미경 (인제대학교 백인제기념임상의학연구소) ,  이정구 (인제대학교 백인제기념임상의학연구소) ,  석대현 (인제대학교 의과대학 생화학교실) ,  표세영 (인제대학교 부산백병원 신경외과학교실) ,  이원희 (인제대학교 부산백병원 신경외과학교실) ,  박성우 (인제대학교 백인제기념임상의학연구소)

초록
AI-Helper 아이콘AI-Helper

우울증은 개인과 사회에 부정적인 영향을 미치는 흔한 정신질환이지만 그 원인은 아직 명확히 밝혀져 있지 않다. 스트레스는 우울증의 주요 위험인자이며, 염증을 유발하여 우울증에 대한 취약성을 증가시키는 것으로 알려져 있다. 수많은 연구는 우울증과 염증의 강한 연관성을 제안하고 있다. 우울증 환자 혈액에서는 IL-1β, IL-6, IL-12, TNF-α 및 IFN-γ와 같은 친염증성 사이토카인이 증가하였으며, IL-4, IL-10 및 TGF-β와 같은 항염증성 사이토카인이 감소하였다. 설치류에 친염증성 사이토카인을 투여하면 우울 유사 행동이 관찰되는 반면, 항염증제를 투여하면 우울 증상이 완화된다. 이러한 연구들은 우울증의 병인에 염증의 중요성을 강조하고 있다. 우울증에서 염증이 활성화되는 기전에 관한 다양한 연구들이 진행되고 있다. 최근 연구에서는 스트레스로 유발되는 무균 염증의 중요성을 밝히고 있다. 병원균의 감염이 없는 상태에서 신체 및 심리적 스트레스로 인해 염증 과정이 활성화되는 것을 무균 염증이라 한다. 스트레스는 무균 염증을 활성화하기 위해 DAMPs (damage-associated molecular patterns)로 알려진 내인성 인자의 방출을 촉진시키며, 방출된 DAMPs는 해당 수용체인 PRRs (pattern recognition receptors)에 결합함으로서 신호전달을 통해 친염증성 사이토카인 생성을 증가시킨다. 본 종설에서 무균 염증의 조절 장애에 대한 전임상 및 임상 증거를 바탕으로 우울증에서 DAMP의 역할을 검토하고자 한다.

Abstract AI-Helper 아이콘AI-Helper

Although depression is a common psychiatric disorder that negatively affects individuals and societies, its exact pathogenesis is not well understood. Stress is a major risk factor for depression and is known to increase susceptibility by triggering inflammation. Indeed, many preclinical and clinica...

주제어

표/그림 (3)

AI 본문요약
AI-Helper 아이콘 AI-Helper

문제 정의

  • 다음은 우울증에서 무균 염증 신호전달과 관련된 다섯가지 DAMPs 인자(HMGB1, S100B, HSP, ATP, 및 요산)의 분자 및 세포 기전을 검토하고자 한다.
  • 최근 여러 연구는 면역 체계의 활성이 우울증 발병에 필수적인 역할을 한다고 보고하여 ‘우울증의 염증 가설’이 대두되었다[33, 48, 56]. 본 리뷰 논문을 통해 우울증 발병에 관한 염증의 관련성을 알아보고, 특히 다양한 임상 및 전임상 연구를 바탕으로 병원체 감염으로 인한 염증이 아닌 스트레스로 인한 무균 염증(sterile inflammation)이 어떠한 기전으로 우울증을 유발하는가에 관해 검토하고자 한다. 이러한 무균 염증의 신호 전달 과정을 이해함으로써, 만성 염증을 가라앉히거나 회복시키는 것이 우울증의 새로운 치료 접근법임을 제시하고, 나아가 우울증 치료를 위한 새로운 약물 표적을 제안하고자 한다.
  • 본 리뷰 논문을 통해 우울증 발병에 관한 염증의 관련성을 알아보고, 특히 다양한 임상 및 전임상 연구를 바탕으로 병원체 감염으로 인한 염증이 아닌 스트레스로 인한 무균 염증(sterile inflammation)이 어떠한 기전으로 우울증을 유발하는가에 관해 검토하고자 한다. 이러한 무균 염증의 신호 전달 과정을 이해함으로써, 만성 염증을 가라앉히거나 회복시키는 것이 우울증의 새로운 치료 접근법임을 제시하고, 나아가 우울증 치료를 위한 새로운 약물 표적을 제안하고자 한다.
본문요약 정보가 도움이 되었나요?

참고문헌 (94)

  1. Alcocer-Gomez, E., Casas-Barquero, N., Williams, M. R.,?Romero-Guillena, S. L., Canadas-Lozano, D., Bullon, P.,?Sanchez-Alcazar, J. A., Navarro-Pando, J. M. and Cordero,?M. D. 2017. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in major depressive?disorder. Pharmacol. Res. 121, 114-121. 

  2. Alcocer-Gomez, E., de Miguel, M., Casas-Barquero, N.,?Nunez-Vasco, J., Sanchez-Alcazar, J. A., Fernandez-Rodriguez, A. and Cordero, M. D. 2014. NLRP3 inflammasome is activated in mononuclear blood cells from?patients with major depressive disorder. Brain Behav.?Immun. 36, 111-117. 

  3. Aliena-Valero, A., Rius-Perez, S., Baixauli-Martin, J.,?Torregrosa, G., Chamorro, A., Perez, S. and Salom, J. B.?2021. Uric acid neuroprotection associated to IL-6/STAT3?signaling pathway activation in rat ischemic stroke. Mol.?Neurobiol. 58, 408-423. 

  4. Alo, R., Mele, M., Fazzari, G., Avolio, E. and Canonaco,?M. 2015. Exposure to sub-chronic unpredictable stress accounts for antidepressant-like effects in hamsters treated?with BDNF and CNQX. Brain Res. Bull. 118, 65-77. 

  5. Arora, P., Sagar, R., Mehta, M., Pallavi, P., Sharma, S.?and Mukhopadhyay, A. K. 2019. Serum S100B levels in?patients with depression. Indian J. Psychiatry 61, 70-76. 

  6. Bahrami, A., Khorasanchi, Z., Sadeghnia, H. R., Tayefi,?M., Avan, A., Ferns, G. A., Bahrami-Taghanaki, H. and?Ghayour-Mobarhan, M. 2019. Depression in adolescent?girls: relationship to serum vitamins a and E, immune response to heat shock protein 27 and systemic inflammation.?J. Affect. Disord. 252, 68-73. 

  7. Bartoli, F., Crocamo, C., Dakanalis, A., Brosio, E., Miotto,?A., Capuzzi, E., Clerici, M. and Carra, G. 2017. Purinergic?system dysfunctions in subjects with bipolar disorder: a comparative cross-sectional study. Compr. Psychiatry 73, 1-6. 

  8. Bhattacharya, A. and Biber, K. 2016. The microglial ATP-gated ion channel P2X7 as a CNS drug target. Glia 64, 1772-1787. 

  9. Blier, P. and de Montigny, C. 1994. Current advances and?trends in the treatment of depression. Trends Pharmacol.?Sci. 15, 220-226. 

  10. Bluthe, R. M., Laye, S., Michaud, B., Combe, C., Dantzer,?R. and Parnet, P. 2000. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced?sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur. J. Neurosci. 12, 4447-4456. 

  11. Bluthe, R. M., Michaud, B., Poli, V. and Dantzer, R. 2000.?Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol. Behav. 70, 367-373. 

  12. Borges, T. J., Lang, B. J., Lopes, R. L. and Bonorino,?C. 2016. Modulation of alloimmunity by heat shock?proteins. Front. Immunol. 7, 303. 

  13. Calderwood, S. K., Gong, J. and Murshid, A. 2016. Extracellular HSPs: the complicated roles of extracellular HSPs?in immunity. Front. Immunol. 7, 159. 

  14. Cao, X., Li, L. P., Wang, Q., Wu, Q., Hu, H. H., Zhang,?M., Fang, Y. Y., Zhang, J., Li, S. J., Xiong, W. C., Yan,?H. C., Gao, Y. B., Liu, J. H., Li, X. W., Sun, L. R., Zeng,?Y. N., Zhu, X. H. and Gao, T. M. 2013. Astrocyte-derived?ATP modulates depressive-like behaviors. Nat. Med. 19, 773-777. 

  15. Capuron, L., Gumnick, J. F., Musselman, D. L., Lawson,?D. H., Reemsnyder, A., Nemeroff, C. B. and Miller, A.?H. 2002. Neurobehavioral effects of interferon-alpha in?cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26, 643-652. 

  16. Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B. and Miller, A. H. 2003. Association?of exaggerated HPA axis response to the initial injection?of interferon-alpha with development of depression during?interferon-alpha therapy. Am. J. Psychiatry 160, 1342-1345. 

  17. Chen, G. Y. and Nunez, G. 2010. Sterile inflammation:?sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837. 

  18. Cheng, Y., Pardo, M., Armini, R. S., Martinez, A., Mouhsine, H., Zagury, J. F., Jope, R. S. and Beurel, E. 2016.?Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to?depression-like behavior. Brain Behav. Immun. 53, 207-222. 

  19. de Rivero Vaccari, J. P., Brand, F. 3rd., Adamczak, S.,?Lee, S. W., Perez-Barcena, J., Wang, M. Y., Bullock, M.?R., Dietrich, W. D. and Keane, R. W. 2016. Exosomemediated inflammasome signaling after central nervous system injury. J. Neurochem. 136, 39-48. 

  20. de Rivero Vaccari, J. P., Dietrich, W. D, and Keane, R,?W, 2016. Therapeutics targeting the inflammasome after?central nervous system injury. Transl. Res. 167, 35-45. 

  21. Deng, Y., Liu, F., Yang, X. and Xia, Y. 2021. The key?role of uric acid in oxidative stress, inflammation, fibrosis,?apoptosis, and immunity in the pathogenesis of atrial?fibrillation. Front. Cardiovasc. Med. 8, 641136. 

  22. Donato, R., Cannon, B. R., Sorci, G., Riuzzi, F., Hsu, K.,?Weber, D. J. and Geczy, C. L. 2013. Functions of S100?proteins. Curr. Mol. Med. 13, 24-57. 

  23. Du, B., Li, H., Zheng, H., Fan, C., Liang, M., Lian, Y.,?Wei, Z., Zhang, Y. and Bi, X. 2019. Minocycline ameliorates depressive-like behavior and demyelination induced?by transient global cerebral ischemia by inhibiting microglial activation. Front. Pharmacol. 10, 1247. 

  24. Duivis, H. E., de Jonge, P., Penninx, B. W., Na, B. Y.,?Cohen, B. E. and Whooley, M. A. 2011. Depressive symptoms, health behaviors, and subsequent inflammation in?patients with coronary heart disease: prospective findings?from the heart and soul study. Am. J. Psychiatry 168, 913-920. 

  25. Duivis, H. E., Kupper, N., Penninx, B. W., Na, B., de?Jonge, P. and Whooley, M. A., 2013. Depressive symptoms and white blood cell count in coronary heart disease?patients: prospective findings from the heart and soul?Study. Psychoneuroendocrinology 38, 479-487. 

  26. Duman, R. S., Heninger, G. R. and Nestler, E. J. 1997.?A molecular and cellular theory of depression. Arch. Gen.?Psychiatry 54, 597-606. 

  27. Duman, R. S. and Monteggia, L. M. 2006. A neurotrophic?model for stress-related mood disorders. Biol. Psychiatry?59, 1116-1127. 

  28. Ehret, M. and Sobieraj, D. M. 2014. Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int. J. Clin. Pract. 68, 255-261. 

  29. Filipovic, D., Zlatkovic, J., Gass, P. and Inta, D. 2013.?The differential effects of acute vs. chronic stress and their?combination on hippocampal parvalbumin and inducible?heat shock protein 70 expression. Neuroscience 236, 47-54. 

  30. Fleshner, M., Frank, M. and Maier, S. F. 2017. Danger?signals and inflammasomes: stress-evoked sterile inflammation in mood disorders. Neuropsychopharmacology?42, 36-45. 

  31. Frank, D., Kuts, R., Tsenter, P., Gruenbaum, B. F., Grinshpun, Y., Zvenigorodsky, V., Shelef, I., Natanel, D., Brotfain, E., Zlotnik, A. and Boyko, M. 2019. The effect of?pyruvate on the development and progression of post-stroke depression: a new therapeutic approach. Neuropharmacology 155, 173-184. 

  32. Frank, M. G., Weber, M. D., Fonken, L. K., Hershman,?S. A., Watkins, L. R. and Maier, S. F. 2016. The redox?state of the alarmin HMGB1 is a pivotal factor in neuro-inflammatory and microglial priming: a role for the?NLRP3 inflammasome. Brain Behav. Immun. 55, 215-224. 

  33. Franklin, T. C., Xu, C. and Duman, R. S. 2018. Depression?and sterile inflammation: essential role of danger associated molecular patterns. Brain Behav. Immun. 72, 2-13. 

  34. Goncalves, F. M., Freitas, A. E., Peres, T. V., Rieger, D.?K., Ben, J., Maestri, M., Costa, A. P., Tramontina, A. C.,?Goncalves, C. A., Rodrigues, A. L., Nagano, C. S., Teixeira, E. H., Nascimento, K. S., Cavada, B. S. and Leal,?R. B. 2013. Vatairea macrocarpa lectin (VML) induces?depressive-like behavior and expression of neuroinflammatory markers in mice. Neurochem. Res. 38, 2375-2384. 

  35. Gonzalez, L. L., Garrie, K. and Turner, M. D. 2020. Role?of S100 proteins in health and disease. Biochim. Biophys.?Acta. Mol. Cell Res. 1867, 118677. 

  36. Harris, H. E., Andersson, U. and Pisetsky, D. S. 2012.?HMGB1: a multifunctional alarmin driving autoimmune?and inflammatory disease. Nat. Rev. Rheumatol. 8, 195-202. 

  37. Hashikawa, N., Utaka, Y., Ogawa, T., Tanoue, R., Morita,?Y., Yamamoto, S., Yamaguchi, S., Kayano, M., Zamami,?Y. and Hashikawa-Hobara, N. 2017. HSP105 prevents depression-like behavior by increasing hippocampal brainderived neurotrophic factor levels in mice. Sci. Adv. 3, e1603014. 

  38. Hodes, G .E., Pfau, M. L., Leboeuf, M., Golden, S. A.,?Christoffel, D. J., Bregman, D., Rebusi, N., Heshmati, M.,?Aleyasin, H., Warren, B. L., Lebonte, B., Horn, S.,?Lapidus, K. A., Stelzhammer, V., Wong, E. H., Bahn, S.,?Krishnan, V., Bolanos-Guzman, C. A., Murrough, J. W.,?Merad, M. and Russo, S. J. 2014. Individual differences?in the peripheral immune system promote resilience versus susceptibility to social stress. Proc. Natl. Acad. Sci. USA.?111, 16136-16141. 

  39. Hung, Y. Y., Huang, K. W., Kang, H. Y., Huang, G. Y.?and Huang, T. L. 2016. Antidepressants normalize elevated?Toll-like receptor profile in major depressive disorder.?Psychopharmacology (Berl) 233, 1707-1714. 

  40. Institute for Health Metrics and Evaluation (IHME). Globa?l Burden of Disease (GBD). Available from: GBD Results?Tool. Accessed 20 February 2022. http://ghdx.healthdata.org/gbd-results-tool?paramsgbd-api-2019-permalink/d780dffbe8a381b25e1416884959e88b 

  41. Iwata, M., Ota, K. T., Li, X. Y., Sakaue, F., Li, N., Dutheil,?S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K.,?Rasmussen, K., Glasebrook, A., Koester, A., Song, D.,?Jones, K. A., Zorn, S., Smagin, G. and Duman, R. S. 2016.?Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol. Psychiatry 80, 12-22. 

  42. Jiang, H., Veldman, E. R., Tiger, M., Ekman, C. J., Lundberg, J. and Svenningsson, P. 2021. Plasma levels of brainderived neurotrophic factor and S100B in relation to antidepressant response to ketamine. Front. Neurosci. 15, 698633. 

  43. Jo, E. K., Kim, J. K., Shin, D. M. and Sasakawa, C. 2016.?Molecular mechanisms regulating NLRP3 inflammasome?activation. Cell Mol. Immunol. 13, 148-159. 

  44. Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B. and?Khandaker, G. M. 2018. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis?of clinical trials of chronic inflammatory conditions. Mol.?Psychiatry 23, 335-343. 

  45. Kim, J. Y., Kim, J. W. and Yenari, M. A. 2020. Heat?shock protein signaling in brain ischemia and injury.?Neurosci. Lett. 715, 134642. 

  46. Kim, Y., Kim, C., Son, S. M., Song, H., Hong, H. S.,?Han, S. H and, Mook-Jung, I. 2016. The novel RAGE?interactor PRAK is associated with autophagy signaling?in Alzheimer's disease pathogenesis. Mol. Neurodegener. 11, 4. 

  47. Klegeris, A. 2021. Regulation of neuroimmune processes?by damage- and resolution-associated molecular patterns.?Neural Regen. Res. 16, 423-429. 

  48. Kohler, O., Krogh, J., Mors, O and, Benros, M. E. 2016.?Inflammation in depression and the potential for anti-inflammatory treatment. Curr. Neuropharmacol. 14, 732-742. 

  49. Koo, J. W., Russo, S. J., Ferguson, D., Nestler, E. J. and?Duman, R. S. 2010. Nuclear factor-kappaB is a critical?mediator of stress-impaired neurogenesis and depressive?behavior. Proc. Natl. Acad. Sci. USA. 107, 2669-2674. 

  50. Kupper, N., Gidron, Y., Winter, J. and Denollet, J. 2009.?Association between type D personality, depression, and?oxidative stress in patients with chronic heart failure.?Psychosom. Med. 71, 973-980. 

  51. Land, W. G. 2015. The role of damage-associated molecular patterns in human diseases: part I - promoting inflammation and immunity. Sultan Qaboos Univ. Med. J. 15, e9-e21. 

  52. Li, X., Wilder-Smith, C. H., Kan, M. E., Lu, J., Cao, Y.?and Wong, R. K. 2014. Combat-training stress in soldiers?increases S100B, a marker of increased blood-brain-barrier?permeability, and induces immune activation. Neuro?Endocrinol. Lett. 35, 58-63. 

  53. Li, Z., Ruan, M., Chen, J. and Fang, Y. 2021. Major depressive disorder: advances in neuroscience research and?translational applications. Neurosci. Bull. 37, 863-880. 

  54. Lu, Y., Zhou, S., Fan, C., Li, J., Lian, Y., Shang, Y. and?Bi, X. 2020. Higher inflammation and cerebral white matter injury associated with cognitive deficit in asthmatic?patients with depression. J. Asthma. 59, 288-296. 

  55. Machado-Santos, A. R., Alves, N. D., Araujo, B., Correia,?J. S., Patricio, P., Mateus-Pinheiro, A., Loureiro-Campos,?E., Bessa, J. M., Sousa, N. and Pinto, L. 2021. Astrocytic?plasticity at the dorsal dentate gyrus on an animal model?of recurrent depression. Neuroscience 454, 94-104. 

  56. Majd, M., Saunders, E. F. H. and Engeland, C. G. 2020.?Inflammation and the dimensions of depression: a review.?Front. Neuroendocrinol. 56, 100800. 

  57. Martinez, J. M., Garakani, A., Yehuda, R. and Gorman,?J. M. 2012. Proinflammatory and ''resiliency" proteins in?the CSF of patients with major depression. Depress.?Anxiety 29, 32-38. 

  58. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. and?Tschopp, J. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241. 

  59. Maslanik, T., Mahaffey, L., Tannura, K., Beninson, L.,?Greenwood, B. N. and Fleshner, M. 2013. The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure. Brain Behav. Immun. 28, 54-62. 

  60. Meyers, A. K. and Zhu, X. 2020. The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging. Cells 29, 1808. 

  61. Miller, A. H., Maletic, V. and Raison, C. L. 2009. Inflammation and its discontents: the role of cytokines in the?pathopyshiology of major depression. Biol. Psychiatry 65, 732-741. 

  62. Ministry of Health and Welfare. OECD health data 2012.?Seoul: Ministry of Health and Welfare; 2012. 

  63. Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K.,?Nemeroff, C. B. and Miller, A. H., 2001. Paroxetine for?the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med. 344, 961-966. 

  64. Musumeci, D., Roviello, G. N. and Montesarchio, D.?2014. An overview on HMGB1 inhibitors as potential?therapeutic agents in HMGB1-related pathologies. Pharmacol. Ther. 141, 347-357. 

  65. Otani, K. and Shichita, T. 2020. Cerebral sterile inflammation in neurodegenerative diseases. Inflamm. Regener. 40, 28. 

  66. Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M.,?Etkin, A., Fava, M., Mohr, D. C. and Schatzberg, A. F. 2016. Major depressive disorder. Nat. Rev. Dis. Primers?2, 16065. 

  67. Pandey, G. N., Rizavi, H. S., Ren, X., Bhaumik, R. and?Dwivedi, Y. 2014. Toll-like receptors in the depressed and?suicide brain. J. Psychiatr. Res. 53, 62-68. 

  68. Pasquali, M. A., Harlow, B. L., Soares, C. N., Otto, M.?W., Cohen, L. S., Minuzzi, L., Gelain, D. P., Moreira,?J. C. F. and Frey, B. N. 2018. A longitudinal study of?neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women. Eur. Arch. Psychiatry?Clin. Neurosci. 268, 771-781. 

  69. Peng, Y. F., Xiang, Y. and Wei, Y. S., 2016. The significance of routine biochemical markers in patients with?major depressive disorder. Sci. Rep. 6, 34402. 

  70. Pereira, D. B., Sannes, T., Dodd, S. M., Jensen, S. E.,?Morgan, L. S. and Chan, E. K., 2010. Life stress, negative?mood states, and antibodies to heat shock protein 70 in?endometrial cancer. Brain Behav. Immun. 24, 210-214. 

  71. Polyakova, M., Sander, C., Arelin, K., Lampe, L., Luck,?T., Luppa, M., Kratzsch, J., Hoffmann, K. T., Riedel-Heller, S., Villringer, A., Schoenknecht, P. and Schroeter,?M. L. 2015. First evidence for glial pathology in late life?minor depression: S100B is increased in males with minor?depression. Front. Cell Neurosci. 9, 406. 

  72. Rana, T., Behl, T., Mehta, V., Uddin, M. S. and Bungau,?S. 2021. Molecular insights into the therapeutic promise?of targeting HMGB1 in depression. Pharmacol. Rep. 73, 31-42. 

  73. Rong, H., Wang, G., Liu, T., Wang, H., Wan, Q. and?Weng, S. 2010. Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid?levels of the neurotrophic factor S100B and its specific?receptor. Int. J. Mol. Sci. 11, 5310-5322. 

  74. Sahin, T. D., Karson, A., Balci, F., Yazir, Y., Bayramgurler, D. and Utkan, T. 2015. TNF-alpha inhibition prevents?cognitive decline and maintains hippocampal BDNF levels?in the unpredictable chronic mild stress rat model of?depression. Behav. Brain Res. 292, 233-240. 

  75. Sarandol, A., Sarandol, E., Acikgoz, H. E., Eker, S. S.,?Akkaya, C. and Dirican, M. 2015. First-episode psychosis?is associated with oxidative stress: effects of short-term?antipsychotic treatment. Psychiatry Clin. Neurosci. 69, 699-707. 

  76. Schroeter, M. L., Steiner, J., Schonknecht, P. and Mueller,?K., 2014. Further evidence for a role of S100B in mood?disorders: a human gene expression mega-analysis. J.?Psychiatr. Res. 53, 84-86. 

  77. Stoffels, M., Zaal, R., Kok, N., van der Meer, J. W. M.,?Dinarello, C. A. and Simon, A. 2015. ATP-induced IL-1β?specific secretion: true under stringent conditions. Front.?Immunol. 6, 54. 

  78. Stroth, N. and Svenningsson, P. 2015. S100B interacts with?the serotonin 5-HT7 receptor to regulate a depressive-like?behavior. Eur. Neuropsychopharmacol. 25, 2372-2380. 

  79. Swaroop, S., Sengupta, N., Suryawanshi, A. R., Adlakha,?Y. K. and Basu, A. 2016. HSP60 plays a regulatory role?in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis. J. Neuroinflammation 13, 27. 

  80. Tao, R. and Li, H. 2015. High serum uric acid level in?adolescent depressive patients. J. Affect. Disord. 174, 464-466. 

  81. Trystula, M., Zychowska, M., Wilk-Franczuk, M., Kropotov, J. D. and Pachalska, M. 2017. CASE-REPORT Dysregulation of gene expression in a patient with depressive?disorder after transient ischemic attack confirmed by a neurophysiological neuromarker. Genet. Mol. Res. 16, doi: 10.4238/gmr16019532. 

  82. Vlachos, I. I., Barbatis, C., Tsopanomichalou, M., AbouAssabeh, L., Goumas, K., Ginieri-Coccossis, M., Economou, M., Papadimitriou, G. N., Patsouris, E. and Nicolopoulou-Stamati, P. 2014. Correlation between depression,?anxiety, and polymorphonuclear cells' resilience in ulcerative colitis: the mediating role of heat shock protein 70.?BMC Gastroenterol. 14, 77. 

  83. Wang, B., Lian, Y. J., Su, W. J., Peng, W., Dong, X.,?Liu, L. L., Gong, H., Zhang, T., Jiang, C. L. and Wang,?Y. X., 2018. HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine?pathway. Brain Behav. Immun. 72, 51-60. 

  84. Wang, C. H., Gu, J. Y., Zhang, X. L., Dong, J., Yang,?J., Zhang, Y. L., Ning, Q. F., Shan, X. W. and Li, Y. 2016. Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression?model. Behav. Brain Funct. 12, 34. 

  85. Wu, M. K., Huang, T. L., Huang, K. W., Huang, Y. L.?and Hung, Y. Y., 2015. Association between toll-like receptor 4 expression and symptoms of major depressive?disorder. Neuropsychiatr. Dis. Treat. 11, 1853-1857. 

  86. Wu, T. Y., Liu, L., Zhang, W., Zhang, Y., Liu, Y. Z., Shen,?X. L., Gong, H., Yang, Y. Y., Bi, X. Y., Jiang, C. L.?and Wang, Y. X. 2015. High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior. J. Psychiatr. Res. 64, 99-106. 

  87. Xie, J., Bi, B., Qin, Y., Dong, W., Zhong, J., Li, M.,?Cheng, Y., Xu, J. and Wang, H. 2021. Inhibition of phosphodiesterase-4 suppresses HMGB1/RAGE signaling pathway and NLRP3 inflammasome activation in mice exposed to chronic unpredictable mild stress. Brain Behav.?Immun. 92, 67-77. 

  88. Xiong, Z., Yang, J., Huang, Y., Zhang, K., Bo, Y., Lu,?X., Su, G., Ma, J., Yang, J., Zhao, L. and Wu, C, 2016.?Serum metabonomics study of anti-depressive effect of?Xiao-chai-Hu-Tang on rat model of chronic unpredictable?mild stress. J. Chromatogr. B. Anal. Technol. Biomed. Life?Sci. 1029-1030, 28-35. 

  89. Yang, K., Xie, G. R., Hu, Y. Q., Mao, F. Q. and Su, L.?Y. 2009. Association study of astrocyte-derived protein?S100B gene polymorphisms with major depressive disorder in Chinese people. Can. J. Psychiatry 54, 312-319. 

  90. Yirmiya, R. 1996. Endotoxin produces a depressive-like?episode in rats. Brain Res. 711, 163-174. 

  91. Yu, C., Zhang, T., Shi, S., Wei, T. and Wang, Q. 2021.?Potential biomarkers: differentially expressed proteins of?the extrinsic coagulation pathway in plasma samples from?patients with depression. Bioengineered 12, 6318-6331. 

  92. Yue, N., Huang, H., Zhu, X., Han, Q., Wang, Y., Li, B.,?Liu, Q., Wu, G., Zhang, Y. and Yu, J. 2017. Activation?of P2X7 receptor and NLRP3 inflammasome assembly in?hippocampal glial cells mediates chronic stress-induced?depressive-like behaviors. J. Neuroinflammation 14, 102. 

  93. Zhang, H., Ding, L., Shen, T. and Peng, D. 2019. HMGB1?involved in stress-induced depression and its neuroinflammatory priming role: a systematic review. Gen. Psychiatr. 32, e100084. 

  94. Zhang, J. C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma,?M. and Hashimoto, K. 2017. Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain?axis. Transl. Psychiatry 7, e1138. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로